Search by Drug Name or NDC

    NDC 62756-0590-18 liothyronine sodium 25 ug/1 Details

    liothyronine sodium 25 ug/1

    liothyronine sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is LIOTHYRONINE SODIUM.

    Product Information

    NDC 62756-0590
    Product ID 62756-590_af12cd5c-3963-4ef2-b819-a42343f0cb69
    Associated GPIs 28100020100310
    GCN Sequence Number 006658
    GCN Sequence Number Description liothyronine sodium TABLET 25 MCG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 26340
    HICL Sequence Number 002850
    HICL Sequence Number Description LIOTHYRONINE SODIUM
    Brand/Generic Generic
    Proprietary Name liothyronine sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name liothyronine sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units ug/1
    Substance Name LIOTHYRONINE SODIUM
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Triiodothyronine [CS], l-Triiodothyronine [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091382
    Listing Certified Through 2024-12-31

    Package

    NDC 62756-0590-18 (62756059018)

    NDC Package Code 62756-590-18
    Billing NDC 62756059018
    Package 1000 TABLET in 1 BOTTLE (62756-590-18)
    Marketing Start Date 2019-11-28
    NDC Exclude Flag N
    Pricing Information N/A